We previously reported a 73-year-old man from a Turkish village whom was detected during family screening (2) . He had irregularly controlled diabetes mellitus for 20 years. When he was 72, he was diagnosed with hepatocellular carcinoma. He died at the age of 73. Although he had two thrombotic risk factors (i.e., cancer and diabetes), he did not experience an overt thromboembolic event. He did not have the factor V 1691 G-A mutation (2) . Further, Alatri et al. (3) reported a 72-yearold man homozygous for the 20210 AA prothrombin mutation without any thromboembolism. These two patients are the oldest homozygous PT 20210 AA so far reported.
As more data accumulates on the asymptomatic cases of homozygous prothrombin 20210 A mutation, the role of this mutation in the pathogenesis of thrombosis will become more clear. Nejat Akar, M.D. Yonca Egin, Bio. Pediatric Molecular Genetics Department of Ankara University, Turkey
